Final results of the randomized phase III CHARTWEL-trial (ARO 97-1) comparing hyperfractionated-accelerated versus conventionally fractionated radiotherapy in non-small cell lung cancer (NSCLC)

Autor:	Baumann, M., Herrmann, T., Koch, R., Matthiessen, W., Appold, S., Wahlers, B., Kepka, L., Marschke, G., Feltl, D., Fietkau, R., Budach, V., Dunst, J., Dziadziuszko, R., Krause, M., Zips, D.
Zdroj:	In Radiotherapy and Oncology July 2011 100(1):76-85
Databáze:	ScienceDirect
Externí odkaz:	Zobrazit plný text záznamu Full Text from ScienceDirect